Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, Invasion, and Angiogenesis in Pancreatic Cancer Cells
Open Access
Abstract
Pancreatic cancer remains a formidable challenge in oncology due to its aggressive nature and limited treatment options. In this study, we investigate the potential therapeutic efficacy of elaiophylin, a novel compound, in targeting BxPC-3 and PANC-1 pancreatic cancer cells. We comprehensively explore elaiophylin’s impact on apoptosis induction, proliferation inhibition, migration suppression, invasion attenuation, and angiogenesis inhibition, key processes contributing to cancer progression and metastasis. The results demonstrate that elaiophylin exerts potent pro-apoptotic effects, inducing a substantial increase in apoptotic cells. Additionally, elaiophylin significantly inhibits proliferation, migration, and invasion of BxPC-3 and PANC-1 cells. Furthermore, elaiophylin exhibits remarkable anti-angiogenic activity, effectively disrupting tube formation in HUVECs. Moreover, elaiophylin significantly inhibits the Wnt/β-Catenin signaling pathway. Our findings collectively demonstrate the multifaceted potential of elaiophylin as a promising therapeutic agent against pancreatic cancer via inhibition of the Wnt/β-Catenin signaling pathway. By targeting diverse cellular processes crucial for cancer progression, elaiophylin emerges as a prospective candidate for future targeted therapies. Further investigation of the in vivo efficacy of elaiophylin is warranted, potentially paving the way for novel and effective treatment approaches in pancreatic cancer management.Keywords
Funding Information
- National Natural Science Foundation of China (81603003, 81772920, 81903829, 2020M080, 2022YFS0620, 2022YFH0115, SKL-QRCM(MUST)-2020-2022, MUST-SKL-2021-00, 2021ZKZD015, 2021ZKZD018, 2021ZKMS046)
- Shandong Science and Technology Program (81603003, 81772920, 81903829, 2020M080, 2022YFS0620, 2022YFH0115, SKL-QRCM(MUST)-2020-2022, MUST-SKL-2021-00, 2021ZKZD015, 2021ZKZD018, 2021ZKMS046)
- Sichuan Science and Technology Program (81603003, 81772920, 81903829, 2020M080, 2022YFS0620, 2022YFH0115, SKL-QRCM(MUST)-2020-2022, MUST-SKL-2021-00, 2021ZKZD015, 2021ZKZD018, 2021ZKMS046)
- Macao Science and Technology Development Fund of Macao SAR (81603003, 81772920, 81903829, 2020M080, 2022YFS0620, 2022YFH0115, SKL-QRCM(MUST)-2020-2022, MUST-SKL-2021-00, 2021ZKZD015, 2021ZKZD018, 2021ZKMS046)
- Southwest Medical University (81603003, 81772920, 81903829, 2020M080, 2022YFS0620, 2022YFH0115, SKL-QRCM(MUST)-2020-2022, MUST-SKL-2021-00, 2021ZKZD015, 2021ZKZD018, 2021ZKMS046)
This publication has 34 references indexed in Scilit:
- Targeting stromal microenvironment in pancreatic ductal adenocarcinoma: controversies and promisesJournal of Gastrointestinal Oncology, 2016
- Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cellsAutophagy, 2015
- Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapiesTherapeutic Advances in Medical Oncology, 2015
- Endothelial Cell Tube Formation Assay for the In Vitro Study of AngiogenesisJournal of Visualized Experiments, 2014
- Pancreatic cancer: why is it so hard to treat?Therapeutic Advances in Gastroenterology, 2013
- Wnt/β-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct4Proceedings of the National Academy of Sciences, 2012
- Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal CancersGastroenterology, 2012
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Wnt signal transduction pathway and apoptosis: a reviewCancer Cell International, 2010
- Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunitiesJournal of Cellular Biochemistry, 2008